BRIEF-Third Point Reports 5.7% Passive Stake In Telephone And Data Systems As Of Dec 17-March 2024-www.financetom.com

BRIEF-Third Point Reports 5.7% Passive Stake In Telephone And Data Systems As Of Dec 17

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Third Point Reports 5.7% Passive Stake In Telephone And Data Systems As Of Dec 17

Dec 26, 2024 3:24 PM

Dec 26 (Reuters) -

* THIRD POINT LLC REPORTS 5.7% PASSIVE STAKE IN TELEPHONE

AND DATA

SYSTEMS AS OF DEC 17 - SEC FILING

Previous page： What's Going On With Pfizer Shares Tuesday? Next page： --Tilray Brands in Talks to Buy Some Molson Coors Brands, Bloomberg Says

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

What's Going On With Pfizer Shares Tuesday?

Aug 13, 2024

Pfizer, Inc. ( PFE ) stock is moving slightly higher on Tuesday. The company on Monday reported top-line results of ABRYSVO, a novel vaccine, for respiratory syncytial virus (RSV) in immunocompromised adults. What To Know: The results indicated that a single dose of ABRYSVO generates strong neutralizing responses against RSV-A and RSV-B in immunocompromised adults aged 18 and older. In addition,...

--Tilray Brands in Talks to Buy Some Molson Coors Brands, Bloomberg Says

Aug 13, 2024

02:00 PM EDT, 08/13/2024 (MT Newswires) -- Price: 1.85, Change: +0.07, Percent Change: +3.64 ...

CSP Shares Fall After Swing to Fiscal Q3 Loss, Drop in Revenue

Aug 13, 2024

02:05 PM EDT, 08/13/2024 (MT Newswires) -- CSP (CSPI) shares were down more than 15% in recent trading Tuesday after the company swung to a fiscal Q3 loss and reported a lower revenue. The company swung to a fiscal Q3 loss of $0.02 per diluted share, compared with an earning of $0.26 a year earlier. Revenue for the quarter ended...

Ocuphire Pharma Shares Fall After Q2 Results

Aug 13, 2024

02:02 PM EDT, 08/13/2024 (MT Newswires) -- Ocuphire Pharma ( OCUP ) shares fell more than 18% in recent trading Tuesday after the clinical-stage ophthalmic biopharmaceutical company posted a wider quarterly loss and lower revenue. The company reported a Q2 net loss earlier in the day of $0.30 per share, widening from $0.24 loss a year earlier. Analysts polled by...